"It's Transforming Medicine" - WSJ

The patent for this breakthrough technology is held by a tiny Micro-Cap trading at less than $10! SPECIAL OPPORTUNITIES [The Oxford Club Special Opportunities]( We have a message from Dylan Jovine at Behind the Markets. While the message that he recently relayed to his readers may not reflect our views, we thought you may be interested in what he has to say... - Rachel Gearhart, Associate Publisher --------------------------------------------------------------- "It's Transforming Medicine" - WSJ Dear Fellow Investor, The medical industry is being dominated by expensive, outdated treatments that can sometimes cause more harm than good. [Click to Play the video.]( But the future of medicine is being driven by a scientific breakthrough deemed "The Holy Grail of Medicine" by The Nobel Laureate Committee. And the crazy thing is... The patent for this breakthrough technology is held by [a tiny Micro-Cap]( trading at less than $10! This technology is such an amazing opportunity that Bill Gates and Google Ventures have invested $120 million into this! [Get all the info here]( "The Buck Stops Here," Dylan Jovine, CEO & Founder Behind the Markets [The Oxford Club] You are receiving this email as a part of your membership in The Oxford Club. Oxford Club Special Opportunities is published by The Oxford Club. To unsubscribe from opportunity based emails like this one, [click here](. Please note that this will not impact the fulfillment of your subscription in any way.. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist The Oxford Club Special Opportunities]( © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [1.800.589.3430](#) | International: [+1.443.353.4334](#) | Fax: [1.410.329.1923](#) [Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.